Prognostic Value of Sequential Measurements of Amino-Terminal Prohormone of B-Type Natriuretic Peptide in Ambulatory Heart Failure Patients
Authors:
- 1 April 2008
- journal article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 10 (4) , 404-411
Abstract
Background: We evaluated the prognostic value of sequential NT-proBNP values in ambulatory heart failure patients after discharge, investigating whether the current value or the recent percent change is more important. Methods and results: In 166 patients, NT-proBNP was measured at discharge from heart failure hospitalisation and three months later. The combined endpoint of death or heart failure rehospitalisation was evaluated after a maximum of 18 months or at follow-up closure. During a mean observation time of 14±4 months, 63 patients (38%) reached the endpoint. In multiple Cox analysis, NT-proBNP three months after discharge (NT-proBNP-3Mo) and NT-proBNP percent change (NT-proBNP-%change) were the only independent predictors of the endpoint among various clinical and laboratory variables. After definition of a high- (n = 83, 57% endpoints) and a low-NT-proBNP patient subgroup (n = 83, 19% endpoints) according to the median NT-proBNP-3Mo (1751 pg/ml), NT-proBNP-%change was the strongest predictor in the high-NT-proBNP subgroup. In the low-NT-proBNP subgroup, NT-proBNP-3Mo was the only independent predictor. Conclusions: In ambulatory heart failure patients, the prognostic value of sequential NT-proBNP measurements depends on the magnitude of the current NT-proBNP value. Recent percent changes in NT-proBNP provide important prognostic information in patients with high NT-proBNP but not in patients with low NT-proBNP.Keywords
This publication has 21 references indexed in Scilit:
- Pre-Discharge B-Type Natriuretic Peptide Predicts Early Recurrence of Decompensated Heart Failure in Patients Admitted to a General Medical UnitEuropean Journal of Heart Failure, 2005
- Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)European Heart Journal, 2005
- How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic reviewBMJ, 2005
- N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure PatientsCirculation, 2004
- Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failureJACC, 2004
- Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)Circulation, 2003
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- More ‘Malignant’ Than Cancer? Five-Year Survival Following a First Admission for Heart FailureEuropean Journal of Heart Failure, 2001
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart FailureCirculation, 1999
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996